市场调查报告书
商品编码
1466635
膜氧供应市场:按类型、年龄层、应用划分 - 2024-2030 年全球预测Membrane Oxygenators Market by Type (Flat Sheet Membrane Oxygenators, Hollow Fiber Membrane Oxygenators), Age Group (Adults, Neonates, Pediatrics), Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
膜氧供应市场规模预计2023年为6.1584亿美元,2024年达到6.5981亿美元,预计2030年将达到9.6762亿美元,复合年增长率为6.66%。
膜氧合器是体外膜氧合 (ECMO) 系统的关键组成部分,该系统透过为患者体外的血液充氧来提供长期的心臟和呼吸支持。膜式供氧市场是指医疗设备业中以膜式供氧系统的设计、製造和销售为主的市场。膜式氧合器市场的成长受到多种因素的影响,例如呼吸系统疾病的增加、技术进步以及全球 ECMO 中心的增加。此外,更容易患慢性病的人口老化和医疗基础设施的改善也促进了成长。政府改善先进医疗保健机会的倡议正在推动市场的进一步成长。然而,ECMO 程序和相关设备的高成本可能会限制资源匮乏地区的市场准入。围绕治疗的复杂性、对医护人员进行专门培训的需要以及出血和感染等併发症的风险的担忧也对市场成长构成了挑战。旨在提高 ECMO 治疗效率和减少併发症的技术创新正在吸引市场机会。用于监控制氧机性能的传感器整合以及用于即时资料分析和患者管理的智慧技术的引入在未来几年也有成长潜力。
主要市场统计 | |
---|---|
基准年[2023] | 61584万美元 |
预测年份 [2024] | 65981万美元 |
预测年份 [2030] | 9.6762亿美元 |
复合年增长率(%) | 6.66% |
类型: 偏好增加
平板膜氧合器是一种用于体外膜氧合(ECMO)系统的气体交换装置。平板膜氧合器使用平板膜促进氧气进入血液并排放血液中的二氧化碳。平板膜氧合器在某些临床环境中是首选,因为它们的初始体积较小,可以最大限度地减少填充氧合器所需的血液量,使它们适合新生儿和儿童患者。另一方面,中空纤维膜供氧装置由一束微孔中空纤维组成,血液透过中空纤维流到外面,并穿过半透膜进行气体交换。中空纤维膜氧合器因其高效的气体交换和比平板式氧合器更低的阻力而被成人 ECMO 广泛首选。
应用:在心臟病领域的多种应用,提供体外循环和供氧
在心臟应用领域,膜氧合器对于在心臟直视手术和其他心血管手术期间需要支援的患者非常重要。膜氧合器提供体外循环和血液氧合,确保重要器官在暂时心臟骤停期间受到保护。心包氧合器需要满足性能标准,例如高气体交换能力、低压降、低预衝量和生物相容性,以最大限度地降低血液凝固和溶血的风险。在体外心肺復苏术 (ECPR) 中,当传统心肺復苏术 (CPR) 无效时,膜氧合器在为心臟麻痹患者提供救生措施方面发挥着至关重要的作用。 ECPR 氧合器必须快速输送氧气,以防止组织缺氧并支持血流动力学,直到心臟功能稳定。膜式氧合器的呼吸应用主要针对对传统机械通气无反应的严重呼吸衰竭患者。薄膜氧合器的任务是去除二氧化碳并提供长期氧气供应,为急性呼吸窘迫症候群(ARDS) 和慢性呼吸道疾病提供长期支援。
区域洞察
由于医疗基础设施的改善以及心血管和呼吸系统疾病的高发病率,美洲,特别是美国和加拿大对膜氧合设备的需求强劲。由于心肺体外迴圈手术的技术创新和COPD(慢性阻塞性肺病)盛行率的上升,美洲地区的市场正在进一步扩大。欧洲国家对病人安全和严格遵守卫生法规表现出了坚定的承诺,从而导致更多地采用高品质标准和高技术合规性。人口老化、严格的法规和政府资助的医疗保健系统等因素正在增加欧洲地区对膜氧合设备的需求。受医疗基础设施开拓和政府医疗支出增加的影响,中东和非洲正逐渐成为膜式氧合器的新兴市场,特别是在波湾合作理事会(GCC)国家。在亚太地区,中国、印度和日本由于人口众多、医疗改革取得进展以及卫生基础设施投资而不断成为重要国家。中国的专利活动反映出对膜式氧合器的成本效益和可扩展製造流程的关注。日本是一个注重技术和品质的成熟市场,而印度是一个快速成长的市场,呼吸系统疾病和心臟病的盛行率不断上升。然而,负担能力和可用性是亚太地区的关键驱动因素,导致对价格敏感的购买行为和对具有成本效益的产品的需求。
FPNV定位矩阵
FPNV定位矩阵对于评估膜氧合装置市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对膜氧设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,以获得市场竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争力评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.膜式供氧装置市场规模及预测如何?
2.膜供氧市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.膜氧供应市场的技术趋势和法规结构是什么?
4.膜式供氧装置市场主要厂商的市场占有率是多少?
5.进入膜氧供应市场的合适形式和策略手段是什么?
[184 Pages Report] The Membrane Oxygenators Market size was estimated at USD 615.84 million in 2023 and expected to reach USD 659.81 million in 2024, at a CAGR 6.66% to reach USD 967.62 million by 2030.
The membrane oxygenator devices are critical components in extracorporeal membrane oxygenation (ECMO) systems, which provide prolonged cardiac and respiratory support by oxygenating a patient's blood outside the body. The membrane oxygenators market refers to the space within the medical devices industry focused on designing, manufacturing, and selling membrane oxygenators. Several factors, such as increasing prevalence of respiratory diseases, technological advancements, and an increase in the number of ECMO centers globally influence the growth of the membrane oxygenators market. Additionally, an aging population susceptible to chronic diseases and improvements in healthcare infrastructure have contributed positively to the expansion. Government initiatives to improve access to advanced healthcare treatments provide further growth impetus for the market. However, the high cost of ECMO procedures and associated equipment can restrict market accessibility in resource-constrained settings. Concerns surrounding the complexity of the treatment, the need for specialized training for healthcare providers, and the risk of complications such as bleeding and infection also pose challenges for market growth. Moreover, technological innovations aimed at increasing efficiency and reducing complications associated with ECMO treatment are attracting opportunities in the market. Integrating sensors to monitor oxygenator performance and incorporating smart technologies for real-time data analysis and patient management also has growth potential in upcoming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 615.84 million |
Estimated Year [2024] | USD 659.81 million |
Forecast Year [2030] | USD 967.62 million |
CAGR (%) | 6.66% |
Type: Increasing preference for flat sheet membrane oxygenators due to low prime volume
Flat sheet membrane oxygenators are a type of gas exchange device used in extracorporeal membrane oxygenation (ECMO) systems. Flat sheet membrane oxygenators employ flat sheet membranes that facilitate the transfer of oxygen into and carbon dioxide out of the blood. Flat sheet membrane oxygenators are often preferred in specific clinical environments due to their low prime volume, which minimizes the amount of blood required to fill the oxygenator, making them suitable for neonatal and pediatric patients. However, hollow fiber membrane oxygenators consist of bundles of microporous hollow fibers through which blood flows externally, and gas exchange occurs across the semipermeable membrane. Hollow fiber membrane oxygenators are widely preferred for adult ECMO due to their efficient gas exchange capabilities and lower resistance compared to flat sheet models.
Application: Diverse applications in cardiac disorders to provide extracorporeal circulation and oxygenation
In the cardiac application segment, membrane oxygenators are critical for patients who require support during open-heart surgery and other cardiovascular procedures. Membrane oxygenators provide extracorporeal circulation and oxygenation of the blood, ensuring vital organs are protected while the heart is temporarily stopped. The performance criteria that determine the preference for a cardiac membrane oxygenator include high gas exchange capacity, low pressure drop, low priming volume, and biocompatibility to minimize the risk of blood clotting and hemolysis. For Extracorporeal Cardiopulmonary Resuscitation (ECPR), membrane oxygenators play a quintessential role in providing life-saving measures for patients in cardiac arrest when conventional CPR is ineffective. ECPR oxygenators must rapidly deliver oxygenation to prevent tissue hypoxia and support hemodynamics until the heart function can be stabilized. Respiratory applications of membrane oxygenators are mainly for patients with severe respiratory failure, unresponsive to conventional mechanical ventilatory support. Membrane oxygenators are tasked with removing CO2 and providing oxygenation over prolonged periods, often in the context of Acute Respiratory Distress Syndrome (ARDS) or for long-term support in chronic respiratory conditions.
Regional Insights
In the Americas, particularly in the United States and Canada, there is a robust demand for membrane oxygenators owing to a well-established healthcare infrastructure and high incidence of cardiovascular and respiratory diseases. Innovations in cardiopulmonary bypass surgery techniques and the rising prevalence of COPD (Chronic Obstructive Pulmonary Disease) further enhance the market in the Americas region. European countries show a deep commitment to patient safety and rigorous adherence to health regulations, leading to the rising adoption of high-quality standards and the implementation of advanced technology compliances. Factors such as an aging population, stringent regulations, and government-funded healthcare systems drive the need for membrane oxygenators in the European region. The Middle East and Africa are gradually emerging markets for membrane oxygenators, influenced by the development of healthcare infrastructure and increased healthcare expenditure by governments, particularly in the Gulf Cooperation Council (GCC) countries. China, India, and Japan have emerged as significant countries in the Asia-Pacific region due to its large population base, increasing healthcare reforms, and investment in healthcare infrastructure. The patent activity in China reflects a focus on cost-effective and scalable manufacturing processes for membrane oxygenators. Japan offers a mature market with emphasis on technology and quality and India is a fast-growing market, with rising prevalence of respiratory and cardiac diseases. However, affordability and accessibility are key drivers in the APAC region, leading to price-sensitive purchasing behavior and a need for cost-effective products.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Membrane Oxygenators Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Membrane Oxygenators Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Membrane Oxygenators Market, highlighting leading vendors and their innovative profiles. These include Alpha Plan GmbH, Braile Biomedica, Chalice Medical Ltd., Cytosorbents Corporation, Elite Lifecare, EUROSETS S.r.l., Fresenius SE & Co KGaA, Gen World Medical Devices, Getinge AB, Harvard Apparatus, Inc., LivaNova PLC, MC3 Cardiopulmonary, Medihub Sciencetec Private Limited, Medtronic PLC, Microport Scientific Corporation, Nipro Corporation, Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shandong Wego New Life Medical Devices Co.,Ltd., Terumo Corporation, and Xenios AG by Fresenius Medical Care AG & Co. KGaA.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Membrane Oxygenators Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Membrane Oxygenators Market?
3. What are the technology trends and regulatory frameworks in the Membrane Oxygenators Market?
4. What is the market share of the leading vendors in the Membrane Oxygenators Market?
5. Which modes and strategic moves are suitable for entering the Membrane Oxygenators Market?